Shandong Iron and Steel Company Ltd. (SHA:600022)

Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	16,222	15,374	14,657	15,834	19,151	15,299
Market Cap Growth	-0.90%	4.89%	-7.43%	-17.32%	25.17%	-2.26%
Enterprise Value	32,423	30,356	30,273	30,687	34,517	32,871
Last Close Price	1.53	1.45	1.37	1.45	1.69	1.32
PE Ratio	-	-	-	28.60	15.59	21.17
Forward PE	-	20.29	20.29	20.29	20.29	20.29
PS Ratio	0.21	0.19	0.16	0.16	0.17	0.18
PB Ratio	0.58	0.55	0.48	0.50	0.59	0.50
P/TBV Ratio	1.25	1.19	0.96	0.92	1.12	0.92
P/FCF Ratio	-	-	-	4.50	3.18	4.13
P/OCF Ratio	77.61	75.92	-	2.90	2.26	2.61
EV/Sales Ratio	0.41	0.37	0.34	0.30	0.31	0.38
EV/EBITDA Ratio	27.91	565.41	13.38	8.06	5.17	6.34
EV/EBIT Ratio	-	-	-	21.12	8.40	12.95
EV/FCF Ratio	-484.24	-	-	8.72	5.72	8.88
Debt / Equity Ratio	0.45	0.47	0.40	0.41	0.42	0.47
Debt / EBITDA Ratio	10.90	84.37	5.15	3.36	2.03	2.77
Debt / FCF Ratio	-	-	-	3.74	2.28	3.87
Asset Turnover	1.16	1.24	1.33	1.44	1.57	1.26
Inventory Turnover	13.61	16.07	17.74	17.44	18.14	16.38
Quick Ratio	0.25	0.20	0.30	0.35	0.37	0.36
Current Ratio	0.45	0.40	0.51	0.56	0.59	0.60
Return on Equity (ROE)	-5.39%	-8.37%	-0.23%	4.40%	9.34%	5.18%
Return on Assets (ROA)	-1.16%	-2.15%	-0.07%	1.28%	3.64%	2.30%
Return on Capital (ROIC)	-1.90%	-3.38%	-0.11%	1.99%	5.61%	3.49%
Return on Capital Employed (ROCE)	-	-	-	3.60%	10.70%	6.70%
Earnings Yield	-10.08%	-14.69%	-2.73%	3.50%	6.41%	4.72%
FCF Yield	-0.41%	-0.90%	-13.02%	22.23%	31.49%	24.20%
Dividend Yield	-	-	-	2.07%	3.55%	3.03%
Payout Ratio	-	-	-	469.81%	66.81%	96.95%
Buyback Yield / Dilution	1.94%	1.01%	-0.04%	-0.10%	0.81%	1.47%
Total Shareholder Return	-	1.01%	-0.04%	1.97%	4.36%	4.49%

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.